Etiology of Sepsis at ICU Admission: A Three-Year Comparative Analysis
Pathogens · 2026-11-06 · 15 (11) · 1167
DOI: 10.3390/pathogens15111167 ↗Abstract
Continuous surveillance of sepsis pathogens informs locally adapted diagnostic and antimicrobial strategies. We assessed temporal changes in sepsis etiology at intensive care unit (ICU) admission before, during, and after the peak of the COVID-19 pandemic. Among 3243 ICU admissions in 2019, 2021, and 2023, 574 patients (18%) presenting with sepsis at admission were included. Blood and other specimens collected within 24 h of admission were analyzed for bacterial, viral, and fungal pathogens. Bacterial pathogens predominated throughout the study period but varied across years (83.2%, 59.2%, 73.0%, respectively; p < 0.001). Viral pathogens peaked in 2021 (36.0%), largely due to SARS-CoV-2, versus 10.3% in 2019 and 11.4% in 2023 (p < 0.001). Fungal pathogens accounted for 15.7% of identified pathogens in 2023, compared with 6.5% in 2019 and 4.8% in 2021 (p < 0.001). In the pre- vs. post-pandemic comparison, Klebsiella pneumoniae increased (11.2% to 22.0%), whereas Acinetobacter baumannii decreased (12.8% to 6.5%). Haemophilus influenzae and Streptococcus pyogenes, absent in 2019, emerged in 2023. Non-albicans Candida species increased in 2023. In conclusion, sepsis etiology changed substantially, with shifts extending beyond the pandemic peak, highlighting the need for ongoing local pathogen surveillance to adapt ICU diagnostic and treatment approaches to evolving pathogen profiles.
EUVIMED